A. Conn

Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom

C. Escriu, J. Lester, E. Hudson, 2021, BMC cancer.

Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom

C. Escriu, J. Lester, E. Hudson, 2020, BMC cancer.

Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use

S. Chan, K. Franks, E. Rathbone, 2020 .